Viewpoint July 30, 2024 Mason Marks, MD, JD1,2 Author Affiliations Article Information JAMA. Published online July 30, 2024. doi:10.1001/jama.2024.13370 On June 4, the Food and Drug Administration (FDA) held a meeting of its Psychopharmacologic Drugs Advisory...
Welcome The MAPS Canada School of Psychedelics The MAPS Canada School of Psychedelics provides education to promote safe, legal, and equitable access to psychedelic medicines. The school provides programs for everyone from clinicians and researchers to policy makers...
Click here for tickets to this event 1 hour 15 minutes Mobile eTicket Welcome to the third installment in our webinar series Balancing Safety and Access in Regulations for Psychedelics, where we explore this complex issue in various contexts and from different...
